Cargando…
Occurence of ArmA and RmtB Aminoglycoside Resistance 16S rRNA Methylases in Extended-Spectrum β-Lactamases Producing Escherichia coli in Algerian Hospitals
The aim of this study, was to characterize the extended-spectrum-β-lactamases (ESBLs) producing clinical strains of Escherichia coli isolated between January 2009 and June 2012 from Algerian hospitals and to determine the prevalence of 16S rRNA methylase among them. Sixty-seven ESBL-producers were d...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018485/ https://www.ncbi.nlm.nih.gov/pubmed/27672380 http://dx.doi.org/10.3389/fmicb.2016.01409 |
_version_ | 1782452914250317824 |
---|---|
author | Ayad, Amel Drissi, Mourad de Curraize, Claire Dupont, Chloé Hartmann, Alain Solanas, Sébastien Siebor, Eliane Amoureux, Lucie Neuwirth, Catherine |
author_facet | Ayad, Amel Drissi, Mourad de Curraize, Claire Dupont, Chloé Hartmann, Alain Solanas, Sébastien Siebor, Eliane Amoureux, Lucie Neuwirth, Catherine |
author_sort | Ayad, Amel |
collection | PubMed |
description | The aim of this study, was to characterize the extended-spectrum-β-lactamases (ESBLs) producing clinical strains of Escherichia coli isolated between January 2009 and June 2012 from Algerian hospitals and to determine the prevalence of 16S rRNA methylase among them. Sixty-seven ESBL-producers were detected among the 239 isolates included: 52 CTX-M-15-producers, 5 CTX-M-3-producers, 5 CTX-M-1-producers, 2 CTX-M-14-producers, 2 SHV-12-producers and one TEM-167-producer. Among the ESBL–producing strains twelve harbored 16S rRNA methylase genes: 8 rmtB and 4 armA. rmtB was located on a IncFIA plasmid and armA was located either on a IncL/M or a IncFIA plasmid. RmtB-producing isolates were genotypically related and belonged to the sequence type ST 405 whereas ArmA-producing isolates belonged to ST10, ST 167, and ST 117. This first description of 16S rRNA methylases among E. coli in Algerian hospitals pointed out the necessity to establish control measures to avoid their dissemination. |
format | Online Article Text |
id | pubmed-5018485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-50184852016-09-26 Occurence of ArmA and RmtB Aminoglycoside Resistance 16S rRNA Methylases in Extended-Spectrum β-Lactamases Producing Escherichia coli in Algerian Hospitals Ayad, Amel Drissi, Mourad de Curraize, Claire Dupont, Chloé Hartmann, Alain Solanas, Sébastien Siebor, Eliane Amoureux, Lucie Neuwirth, Catherine Front Microbiol Microbiology The aim of this study, was to characterize the extended-spectrum-β-lactamases (ESBLs) producing clinical strains of Escherichia coli isolated between January 2009 and June 2012 from Algerian hospitals and to determine the prevalence of 16S rRNA methylase among them. Sixty-seven ESBL-producers were detected among the 239 isolates included: 52 CTX-M-15-producers, 5 CTX-M-3-producers, 5 CTX-M-1-producers, 2 CTX-M-14-producers, 2 SHV-12-producers and one TEM-167-producer. Among the ESBL–producing strains twelve harbored 16S rRNA methylase genes: 8 rmtB and 4 armA. rmtB was located on a IncFIA plasmid and armA was located either on a IncL/M or a IncFIA plasmid. RmtB-producing isolates were genotypically related and belonged to the sequence type ST 405 whereas ArmA-producing isolates belonged to ST10, ST 167, and ST 117. This first description of 16S rRNA methylases among E. coli in Algerian hospitals pointed out the necessity to establish control measures to avoid their dissemination. Frontiers Media S.A. 2016-09-12 /pmc/articles/PMC5018485/ /pubmed/27672380 http://dx.doi.org/10.3389/fmicb.2016.01409 Text en Copyright © 2016 Ayad, Drissi, de Curraize, Dupont, Hartmann, Solanas, Siebor, Amoureux and Neuwirth. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Ayad, Amel Drissi, Mourad de Curraize, Claire Dupont, Chloé Hartmann, Alain Solanas, Sébastien Siebor, Eliane Amoureux, Lucie Neuwirth, Catherine Occurence of ArmA and RmtB Aminoglycoside Resistance 16S rRNA Methylases in Extended-Spectrum β-Lactamases Producing Escherichia coli in Algerian Hospitals |
title | Occurence of ArmA and RmtB Aminoglycoside Resistance 16S rRNA Methylases in Extended-Spectrum β-Lactamases Producing Escherichia coli in Algerian Hospitals |
title_full | Occurence of ArmA and RmtB Aminoglycoside Resistance 16S rRNA Methylases in Extended-Spectrum β-Lactamases Producing Escherichia coli in Algerian Hospitals |
title_fullStr | Occurence of ArmA and RmtB Aminoglycoside Resistance 16S rRNA Methylases in Extended-Spectrum β-Lactamases Producing Escherichia coli in Algerian Hospitals |
title_full_unstemmed | Occurence of ArmA and RmtB Aminoglycoside Resistance 16S rRNA Methylases in Extended-Spectrum β-Lactamases Producing Escherichia coli in Algerian Hospitals |
title_short | Occurence of ArmA and RmtB Aminoglycoside Resistance 16S rRNA Methylases in Extended-Spectrum β-Lactamases Producing Escherichia coli in Algerian Hospitals |
title_sort | occurence of arma and rmtb aminoglycoside resistance 16s rrna methylases in extended-spectrum β-lactamases producing escherichia coli in algerian hospitals |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018485/ https://www.ncbi.nlm.nih.gov/pubmed/27672380 http://dx.doi.org/10.3389/fmicb.2016.01409 |
work_keys_str_mv | AT ayadamel occurenceofarmaandrmtbaminoglycosideresistance16srrnamethylasesinextendedspectrumblactamasesproducingescherichiacoliinalgerianhospitals AT drissimourad occurenceofarmaandrmtbaminoglycosideresistance16srrnamethylasesinextendedspectrumblactamasesproducingescherichiacoliinalgerianhospitals AT decurraizeclaire occurenceofarmaandrmtbaminoglycosideresistance16srrnamethylasesinextendedspectrumblactamasesproducingescherichiacoliinalgerianhospitals AT dupontchloe occurenceofarmaandrmtbaminoglycosideresistance16srrnamethylasesinextendedspectrumblactamasesproducingescherichiacoliinalgerianhospitals AT hartmannalain occurenceofarmaandrmtbaminoglycosideresistance16srrnamethylasesinextendedspectrumblactamasesproducingescherichiacoliinalgerianhospitals AT solanassebastien occurenceofarmaandrmtbaminoglycosideresistance16srrnamethylasesinextendedspectrumblactamasesproducingescherichiacoliinalgerianhospitals AT sieboreliane occurenceofarmaandrmtbaminoglycosideresistance16srrnamethylasesinextendedspectrumblactamasesproducingescherichiacoliinalgerianhospitals AT amoureuxlucie occurenceofarmaandrmtbaminoglycosideresistance16srrnamethylasesinextendedspectrumblactamasesproducingescherichiacoliinalgerianhospitals AT neuwirthcatherine occurenceofarmaandrmtbaminoglycosideresistance16srrnamethylasesinextendedspectrumblactamasesproducingescherichiacoliinalgerianhospitals |